Zoledronic acid


( Last Updated : July 20, 2011)
Generic Name:
Zoledronic acid
Project Status:
Complete
Therapeutic Area:
Osteoporosis
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Brand Name:
Aclasta
Project Line:
Reimbursement Review
Project Number:
SF0242-000

Details


Submission Type:
Request For Advice
Indications:
Osteoporosis (postmenopausal women)
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: